Search Results - David J. Friedman

Refine Results
  1. 1
    Genetics of kidney failure and the evolving story of APOL1

    Genetics of kidney failure and the evolving story of APOL1 by David J. Friedman, Martin R. Pollak

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Apolipoprotein L1 and Kidney Disease in African Americans

    Apolipoprotein L1 and Kidney Disease in African Americans by David J. Friedman, Martin R. Pollak

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    APOL1 Nephropathy: From Genetics to Clinical Applications

    APOL1 Nephropathy: From Genetics to Clinical Applications by David J. Friedman, Martin R. Pollak

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene – Proceedings of the Henry Shavelle Professorship

    APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene – Proceedings of the Henry Shavelle Professorship by Martin R. Pollak, David J. Friedman

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.

    Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. by C J Li, Chao Wang, David J. Friedman, A B Pardee

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Population-Based Risk Assessment of APOL1 on Renal Disease

    Population-Based Risk Assessment of APOL1 on Renal Disease by David J. Friedman, Julia Kozlitina, Giulio Genovese, Prachi Jog, Martin R. Pollak

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    CD39 and control of cellular immune responses

    CD39 and control of cellular immune responses by Karen M. Dwyer, Silvia Deaglio, Wenda Gao, David J. Friedman, Terry B. Strom, Simon C. Robson

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background

    Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background by Herbert Lannon, Shrijal S. Shah, Leny Dias, Daniel Blackler, Seth L. Alper, Martin R. Pollak, David J. Friedman

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore

    APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore by Shrijal S. Shah, Herbert Lannon, Leny Dias, Jia-Yue Zhang, Seth L. Alper, Martin R. Pollak, David J. Friedman

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    APOL1 genotyping is incomplete without testing for the protective M1 modifier p.N264K variant

    APOL1 genotyping is incomplete without testing for the protective M1 modifier p.N264K variant by Rasheed Gbadegesin, Elena Martinelli, Yask Gupta, David J. Friedman, Matthew G. Sampson, Martin R. Pollak, Simone Sanna‐Cherchi

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Most ApoL1 Is Secreted by the Liver

    Most ApoL1 Is Secreted by the Liver by Khuloud Shukha, Jessica L. Mueller, Raymond T. Chung, Michael P. Curry, David J. Friedman, Martin R. Pollak, Anders H. Berg

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Functional Comparison of Mouse slc26a6 Anion Exchanger with Human SLC26A6 Polypeptide Variants

    Functional Comparison of Mouse slc26a6 Anion Exchanger with Human SLC26A6 Polypeptide Variants by Marina N. Chernova, Lianwei Jiang, David J. Friedman, Rachel Darman, Hannes Lohi, Juha Kere, David H. Vandorpe, Seth L. Alper

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    <i>APOL1</i> Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults

    <i>APOL1</i> Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults by Kenneth J. Mukamal, Joseph Tremaglio, David J. Friedman, Joachim H. Ix, Lewis H. Kuller, Russell P. Tracy, Martin R. Pollak

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation.

    The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. by J S Culp, L C Webster, David J. Friedman, C. Smith, Wei Huang, Felicia Y.-H. Wu, Martin Rosenberg, Robert P. Ricciardi

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model

    Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model by Gwendolyn J. McGinnis, David J. Friedman, Kristina H. Young, Eileen Ruth S. Torres, Charles R. Thomas, Michael J. Gough, Jacob Raber

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins

    BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins by John F. Heneghan, David H. Vandorpe, Boris E. Shmukler, Joseph GIovinazzo, Jayne Raper, David J. Friedman, Martin R. Pollak, Seth L. Alper

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models

    TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models by Kristina H. Young, Pippa Newell, Benjamin Cottam, David J. Friedman, Talicia Savage, Jason R. Baird, Emmanuel T. Akporiaye, Michael J. Gough, Marka R. Crittenden

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

    CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease by David J. Friedman, Beat Künzli, Yousif I. A-Rahim, Jean Sévigny, Pascal O. Berberat, Keiichi Enjyoji, Eva Csizmadia, Helmut Frieß, Simon C. Robson

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

    Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors by Jason R. Baird, David J. Friedman, Benjamin Cottam, Thomas W. Dubensky, David B. Kanne, Shelly Bambina, Keith S. Bahjat, Marka R. Crittenden, Michael J. Gough

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity

    Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity by Justin Chun, Jia-Yue Zhang, Maris S. Wilkins, Balajikarthick Subramanian, Cristian V. Riella, Jose M. Magraner, Seth L. Alper, David J. Friedman, Martin R. Pollak

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: